Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Shattuck Labs Inc (STTK)

Shattuck Labs Inc (STTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Shattuck Labs Inc 500 W. 5TH STREET SUITE 1200 AUSTIN TX 78701 USA

www.shattucklabs.com Employees: 75 P: 512-900-4690

Description:

Shattuck Labs Inc. is a clinical-stage biotechnology company. It engages in development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of cancer and autoimmune disease. The company's wholly owned program includes SL-172154. It operates principally in Durham, North Carolina and Austin, Texas. Shattuck Labs Inc. is based in Austin, United States.

Key Statistics

Overview:

Market Capitalization, $K 54,901
Enterprise Value, $K -70,729
Shares Outstanding, K 47,740
Annual Sales, $ 1,660 K
Annual Net Income, $ -87,300 K
Last Quarter Sales, $ 3,000 K
Last Quarter Net Income, $ -16,680 K
EBIT, $ -79,870 K
EBITDA, $ -77,310 K
60-Month Beta 1.76
% of Insider Shareholders 10.50%
% of Institutional Shareholders 58.74%
Float, K 42,727
% Float 89.50%
Short Volume Ratio 0.69

Growth:

1-Year Return -82.17%
3-Year Return -87.08%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.33 on 11/14/24
Next Earnings Date N/A
Earnings Per Share ttm -1.53
EPS Growth vs. Prev Qtr 21.43%
EPS Growth vs. Prev Year 49.23%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

STTK Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -61.92%
Return-on-Assets % -54.50%
Profit Margin % -5,259.04%
Debt/Equity 0.00
Price/Sales 29.96
Price/Cash Flow N/A
Price/Book 0.51
Book Value/Share 2.02
Interest Coverage -3.52
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar